16:50 EST DBV Technologies (DBVT) trading resumes
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DBVT:
- DBV Technologies reports VITESSE trial meets primary endpoint
- DBV Technologies trading halted, news pending
- DBV Technologies initiated with an Overweight at Cantor Fitzgerald
- DBV Technologies price target raised to $35 from $20 at H.C. Wainwright
- Guggenheim starts DBV Technologies at Buy on peanut allergy market potential